Yea they seem to be playing hard ball. You need to admire Tibotec… They get all the benefit of seeing how a drug goes over the next few months and no cost.
As frustrating as it is, I don’t know how much the directors of AVX can do against Pharmas that obviously hold all of the cards.
Still, the news could be a lot worse – Atleast they are still interested in the pipeline.
